The present invention relates to a compound of diclofenac-tramadol salt in 1:1 ratio and a pharmaceutical formulation comprising such compound. The present invention also relates to a method for treating a patient with moderate to moderately severe pain. The method comprises: identifying a patient suffering from moderate to moderately severe pain with pain intensity scale of 5-9 and administering to said patient the diclofenac-tramadol salt in an effective amount. The method is particularly usef...

The present invention provides an injectable pharmaceutical composition containing as an active ingredient paclitaxel an anti-cancer agent. The injectable pharmaceutical composition comprises an effective amount of paclitaxel which is dissolved in polyoxyethylated castor oil alcohol and an injectable aqueous solution. A sufficient amount of CO 2 is added to stabilize paclitaxel in the injectable pharmaceutical composition to make the injectable pharmaceutical composition to a pH about 5.0.

The present invention relates to a fast-release as well as a prolonged release type of nifedipine pellets and the process for the preparation thereof. The fast-release type of nifedipine pellets comprises a particulate core which is covered by a nifedipine coating layer. The particulate core comprises water-soluble or water-insoluble excipient(s) and a pharmacologically acceptable carrier. The nifedipine coating layer comprises an effective amount of nifedipine dissolved in organic solvent(s). T...